Andrés Elía

2PUBLICATIONS
23CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Apr 04, 2026
Nuclear FGF2, androgen receptor and Wnt pathway activation define a targetable subset of antiprogestin-resistant luminal breast cancer.

Virginia Figueroa, Marcela I Coianis, Ana Sahores

|Oct 21, 2022
Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial.

Andrés Elía, Leo Saldain, Silvia I Vanzulli

Pageof 1

Frequent Collaborators

2 joint publications

Caroline A Lamb

2 joint publications

Martín C Abba

1 joint publications

Leo Saldain

1 joint publications

Silvia I Vanzulli